Global CBD Ingredient Market, by Source,
Global CBD Ingredient Market, by Application,
Global CBD Ingredient MarketBy Formulation
Global CBD Ingredient Market, by Region,
North America CBD Ingredient Market, by Country,
Europe CBD Ingredient Market, by Country,
Asia Pacific CBD Ingredient Market, by Country,
Latin America CBD Ingredient Market, by Country,
Middle East & Africa CBD Ingredient Market, by Country,
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global CBD Ingredient Market Snapshot
Chapter 4. Global CBD Ingredient Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Source, Estimates & Trend Analysis
5.1. By Source, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Source:
5.2.1. Natural
5.2.1.1. Marijuana Based
5.2.1.2. Hemp Based
5.2.2. Synthetic
Chapter 6. Market Segmentation 2: By Application Type Estimates & Trend Analysis
6.1. By Application Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application Type:
6.2.1. Food and Beverages
6.2.2. Personal Care and Cosmetics
6.2.3. Nutraceuticals
6.2.4. Pharmaceutical (API)
6.2.5. Others (Pet Care, Wellness and Alternative Medicine, etc.)
Chapter 7. Market Segmentation 2: By Application Type Estimates & Trend Analysis
7.1. By Application Type & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application Type:
7.2.1. Oils and Tinctures
7.2.2. Topicals
7.2.3. Edibles
7.2.4. Capsules and Softgels
7.2.5. Others
Chapter 8. CBD Ingredient Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America CBD Ingredient Market revenue (US$ Million) estimates and forecasts By Source, 2021-2034
8.1.2. North America CBD Ingredient Market revenue (US$ Million) estimates and forecasts By Application Type, 2021-2034
8.1.3. North America CBD Ingredient Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe CBD Ingredient Market revenue (US$ Million) By Source, 2021-2034
8.2.2. Europe CBD Ingredient Market revenue (US$ Million) By Application Type, 2021-2034
8.2.3. Europe CBD Ingredient Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific CBD Ingredient Market revenue (US$ Million) By Source, 2021-2034
8.3.2. Asia Pacific CBD Ingredient Market revenue (US$ Million) By Application Type, 2021-2034
8.3.3. Asia Pacific CBD Ingredient Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America CBD Ingredient Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
8.4.2. Latin America CBD Ingredient Market revenue (US$ Million) By Application Type, (US$ Million) 2021-2034
8.4.3. Latin America CBD Ingredient Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa CBD Ingredient Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
8.5.2. Middle East & Africa CBD Ingredient Market revenue (US$ Million) By Application Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa CBD Ingredient Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. DSM
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Vantage Hemp.
9.2.3. Eurofins
9.2.4. EndoPure
9.2.5. Folium Biosciences
9.2.6. Colombian Golden
9.2.7. Averix Bio, LLC
9.2.8. KND Labs
9.2.9. Jordan Process
9.2.10. GVB Biopharma
9.2.11. Mile High Labs
9.2.12. Sanobiotec
9.2.13. Caesar & Loretz GmbH
9.2.14. Recipharm
9.2.15. Brains Bioceutical
9.2.16. Purisys
9.2.17. Bedrocan
9.2.18. BIOVECTRA Inc.
9.2.19. Biosyyd, UAB
9.2.20. Kinetochem
9.2.21. Veranova
9.2.22. Other Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.